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In a  preliminary communication (1), we reported that human serum inacti- 
vated endotoxin derived from bacterial, mammalian and plant sources but that 
serum of rabbits and mice did not possess this property. In the accompanying 
report (2) these observations were extended to the examination of the sera from 
nine mammalian species. In each of these species the relative effectiveness of 
citrated plasma and serum in the inactivation of endotoxin was compared. As 
regards this property of blood the comparison consistently showed that serum 
was either of low activity or inactive whereas citrated plasma was uniformly 
more potent. The nature of this striking difference between serum and plasma 
has been investigated. The various experiments reported here ultimately led to 
the understanding that the presence in serum of calcium, which suppresses the 
activity of this endotoxin detoxifying component (EDC), can account for this 
difference, and that the enhanced effectiveness of plasma in the inactivation of 
endotoxin is dependent on the binding or removal of calcium ion. 
Materials  and Methods 
The materials and methods employed in this work do not significantly differ from those 
given in detail in the accompanying paper (2) as regards the fonowing: the collection and 
processing of blood; the source and dose of endotoxin; the procedure for conducting the in 
dtro interaction between endotoxin and the various blood specimens being tested for their 
EDC activity; the assay for unaltered residual endotoxin in the reaction mixtures as measured 
by induced hemorrhagic necrosis in mouse tumors. 
EXPERIMENTAL 
The finding that most sera differed markedly from citrated plasma in EDC 
activity was consistent in the various species in which they were tested. In an 
attempt to explain this difference, citrated plasma was clotted by recalcification. 
The clot which formed was removed and this recalcified plasma was assayed for 
EDC activity. It was found to have none. The possibility was then considered 
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that this difference between serum and plasma was related to clot formation. 
It was thought that EDC might be adsorbed  to the fibrin clot. However  at- 
tempts to elute the activity from the clot were  totally unsuccessful.  Other 
possible explanations  were therefore  investigated such as the consumption  of 
this activity in the early stages of the clotting process, and of its identity with 
one of the clotting factors. It was readily demonstrated that the formation of 
thromboplastin  and  the  conversion  of  prothrombin  to  thrombin  were  not 
associated  with EDC activity. However in the course of these experiments  it 
became apparent that the addition of calcium to plasma resulted in the loss of 
EDC  activity, even when clot formation was prevented by the addition of 
TABLE I 
Suppression of EDC Actgvity of Plasma by Addition of Divalent Cations 
Human plasma* 
Resin-treated and 
defibrinted 
with bovine 
thrombin 
~mount 
ml. 
0.04 
Divalent 
cation 
Ca++ 
Mg+ + 
Mn++ 
Ba++ 
None 
Amount added 
1.1X 10-~ 
Endotoxin 
10 pg. Serf. 
f?zafcesc~tzs 
Induced 
tumor 
damage~: 
8/9 
t0/lo 
7/9 
9/9 
1/10 
Inactivation 
of endotoxin 
None 
gc 
c~ 
c~ 
Complete 
* This plasma contained 2.2 mg. per cent of calcium or 0.06 X  10  -a M. 
No. of mice with damaged tumors/total No. of mice tested. 
heparin.  Furthermore, when blood was collected in heparin,  the plasma thus 
obtained was no different from serum in its EDC activity. Findings such as 
these showed clearly that clotting per se was not implicated in the observed dif- 
ference in EDC activity between serum and plasma. 
Effect of Divalent Cations on EDC A ctidty.--From the preceding observations 
it eventually became evident that the loss of EDC which followed recalcifica- 
tion of citrated plasma was independent of clot formation and was due solely 
to suppression of EDC activity by calcium. This led to an examination of the 
influence of this and other divalent cations upon the inactivation of endotoxin 
by serum and plasma. 
In order to define better the role of divalent cations in this system it was 
necessary to avoid the complication posed by the clotting of plasma.  To this 
end, citrated plasma was treated with bovine thrombin to remove its fibrinogen 
content. Following removal of the clot, this thrombin-treated plasma retained 
undiminished  EDC  activity. Addition of the amount of calcium  previously 
employed to recalcify citrated plasma (0.025 ml. •  CaCl#ml. plasma) resulted 
in total suppression of EDC activity. Table I shows that this effect of calcium ROSEN,  SKARNES,  LANDY,  AND  SHEAR  703 
was  duplicated  with  analogous  concentrations of MgCh,  MnC12, and BaC12. 
The divalent cations of cobalt, copper, and iron did not inhibit EDC. 
To determine the amount of calcium required for this inhibitory effect it was 
desirable to obtain plasma  to which calcium-binding agents,  such as sodium 
citrate, had not been added. In order to obtain such a preparation, blood from 
human donors was collected in a Fenwal cation exchange pack and then passed 
through the resin a second time..The plasmas were separated from the cellular 
elements and assayed for EDC activity. These resin-treated plasmas were as 
TABLE II 
Suppression by Calcium of EDC Activity in Resin-Treated Plasma 
Human ion-exchange  plasma 
Donor 
~o. 1, contained 3 mg. 
per cent calcium 
So. 2, contained 2.2 mg. 
per cent calcium 
Amount 
ml. 
0.03  -- 
0.03 
Calcium 
concentration 
Amount  Total 
added  amount 
rag. per  rag.  per 
GCn~  ¢ent 
3 
2  5 
3  6 
4  7 
--  2.2 
3  5.2 
4  6.2 
Endotoxin 
10 t~g. Serr. 
marce$c~,~ 
10 t~g. Serr. 
mafcesc~s 
Induced  Inactivation 
tumor  of endotoxin  damage* 
0/9  Complete 
0/9  " 
4/9  Partial 
9/9  None 
0/9  Complete 
o/lo  ,, 
7/9  None 
* No. of mice with damaged tumors/total No. of mice tested. 
potent as citrated plasma in the inactivation of endotoxin; the  total calcium 
content of plasma from two donors was 2.2 and 3 rag. per cent as determined 
by flame spectrophotometry. As is shown in Table II, 0.03 ml. of these plasmas 
sufficed to inactivate the test dose of endotoxin. Graded amounts of calcium 
chloride were added to aliquots of each of these samples prior to their incuba- 
tion with the standard dose of endotoxin. When the total calcium content of the 
plasma (i.e. residual +  added calcium) was brought above 6 rag. per cent its 
EDC  activity was  completely suppressed; at  this calcium level, clotting oc- 
curred.  These  tests  were  therefore repeated with  resin-treated plasma  from 
which fibrinogen had been removed with bovine thrombin. Here, too, in the 
absence of clot formation, the total calcium level required for the suppression of 
EDC activity was 6 rag. per cent. Mg  ++, Mn  +~, and Ba  ++, the other divalent 
cations which had previously been shown to suppress EDC also interfered with 
the activity of this preparation. 
Effect  of  Anticoagulants.--When  it  was  established  that  the  addition  of 
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that the generally low potency of serum might be due to its greater calcium 
content.  If  this were  the  case, it would be anticipated that the addition to 
serum of calcium-binding anticoagulants would cause the serum to become as 
effective as plasma in the inactivation of endotoxin. This indeed proved to be 
the case. The effectiveness of anticoagulants was  determined in experiments 
which  utilized  rabbit  serum  lacking  measurable  EDC  activity  and  human 
serum of low potency. As seen in Table III, the quantities of these sera era- 
TABLE  III 
E~ect of Calcium-Binding Agents on EDC Actirily 
Reaction mixture 
Blood preparation 
Rabbit serum 
Humall  serum 
Human ion ex- 
change plasma, 
dialyzed 
~o~t 
m|. 
0.1 
0.2 
0.03 
Calcium-binding  agent 
None 
Sodium citrate 
' '  oxalate 
"  fluoride 
EDTA 
None 
Sodium citrate 
' '  oxalate 
EDTA 
None 
Sodium oxalate 
"  fluoride 
EDTA 
Con- 
centga- 
10s 
2 
1 
1.6 
0.3 
2 
1 
0.3 
I 
1.6 
0.3 
Endotoxin 
10 ug. Serr. 
m~fce$c~$ 
10 ~g. Serf. 
m~rc~$ccfM 
10 ~g. Serf. 
marcesG~$ 
nduce~ 
tumog 
dam- 
age* 
7/9 
0/9 
0/9 
0/9 
0/9 
7/9 
o/10 
0/9 
1/9 
7/10 
o/10 
1/9 
o/lo 
Inactivation 
of endotoxln 
None 
Complete 
ct 
None 
Complete 
cc 
None 
Complete 
¢c 
cl 
* No. of mice with damaged tumors/total No. of mice tested. 
ployed failed to affect the tumor-damaging potency of the standard  dose of 
endotoxin. However, the addition of sodium citrate, sodium oxalate, sodium 
fluoride,  or  EDTA,  resulted  in  a  product which,  in  its  EDC  potency, was 
comparable to  the  homologous plasma.  The amounts  of each of these anti- 
coagulants needed to achieve this effect were the same as those required to 
prevent coagulation of whole blood. Lesser amounts of these agents did not 
restore EDC  activity to serum.  In contrast to the pronounced effects of the 
aforementioned agents, heparin, an anticoagulant which does not bind calcium, 
is wholly without effect on EDC activity; i.e.,  heparinized plasma and serum 
exhibit similar potencies. 
Effect of Dialysis  of Plasma.--In  the initial phases  of determining the in- 
hibitory effect of calcium on EDC,  attempts were made to remove calcium ROSEN~ SKARNES, LANDY, AND SHEAR  705 
from citrated plasma  by dialysis for 24 to 48 hours against  100  volumes of 
distilled  water,  at  4°C.  The  euglobulins,  which  precipitated,  contained  no 
EDC activity and therefore were discarded. The activity was present in the 
supernatant fluid but the potency was now markedly diminished. For example, 
where 0.01 ml. of human plasma sufficed to inactivate the standard dose of en- 
dotoxin before dialysis, after this treatment 0.2 to 0.4 ml. was required for com- 
parable effect (see Table IV). The dialyzed plasma was found to contain less 
than 1 rag. per cent of total calcium by flame spectrophotometry. It was there- 
fore anticipated that only 0.1  the amount of oxalate or citrate now would be 
required to fully  restore the EDC activity. Contrary to expectations this amount 
of oxalate or citrate failed to increase the potency of the dialyzed plasma. How- 
TABLE IV 
Effect of Dialysis on EDC Acgvity of Human Plasma 
Htl]~tll pl~s11~ 
Ion exchange (donor No.i) ...... 
Ion exchange (donor No. 2) ...... 
ACD-pooled  ................... 
Before dialysis 
Vol. of plasma 
reacted with 
I0  ~g. Serf. 
raarcezcen$ 
endotoxin 
mL 
0.03 
0.03 
0.01 
Induced  tumor 
damage*  [ 
O/lO 
O/lO 
O/lO 
After dialysis 
Vol. of plasma 
reactedwith  Induced tumor 
10 pg. S*rr.  damage* 
ffSafCeSC$~$$ 
endotoxin 
ral. 
0.03  9/lO 
0.03  8/9 
0.01  7/9 
* No. of mice with damaged tumors/total No. of mice tested. 
ever the EDC activity was restored completely when the amount of oxalate or 
citrate was  increased  tenfold; this  is  the  amount  required  to  render serum 
active. These observations were duplicated with sodium fluoride and EDTA. 
It was thus reasoned that the effect of these anticoagulants in the endotoxin- 
inactivation system was not limited to their capacity to bind calcium. 
Evidence for a Dialyzable Component.--The preceding section described ex- 
periments in which dialysis of citrated plasma greatly reduced EDC potency. It 
was  found that  the activity could be restored upon the addition of its own 
dialysate. Since the plasma contained added citrate it was at first considered 
that the citrate present in the dialysate was responsible for this effect. In order 
to determine whether this effect was indeed due to citrate, it was necessary to 
obtain dialyzate from plasma to which no anticoagulant had been added. Thus 
a potent resin-treated plasma was dialyzed against 10 volumes of distilled water 
for 24 hours at 4°C. The dialysate was lyophilized and taken up to one-half the 
original volume in water. The dialyzed, resin-treated plasma  which had lost 
appreciable EDC activity (see Table nI) was restored to its original potency by 
the addition of dialysate in an amount equal to that  originally present; the 
dialysate itself did not possess any activity. Thus it is seen that blood contains 706  INACTIVATION  OF  ENDOTOXIN  BY  HUMORAL  COMPONENT.  III 
dialyzable material which is required, together with EDC, for the inactivation 
of endotoxin. 
Table V  shows that resin-treated, dialyzed human plasma, which no longer 
exhibited EDC activity at 0.03 ml., had its activity completely restored by the 
addition of dialysate. Indeed the dialysate still manifested this effect even after 
it had been boiled for 30 minutes or had been incinerated for 15 minutes. This 
evidence implies that the component in the dialysate is of inorganic composition.  I 
Effect of EDC in Other Host Reactions to Endotoxin.--The foregoing effects of 
calcium and  calcium-binding anticoagulants  on EDC  activity were observed 
with the reaction of tumors in mice as the sole indicator of host response to 
endotoxin. Preparatory activity for the Shwartzman reaction and lethality for 
rabbits were used to measure the extent of inactivation of endotoxin by EDC, 
TABLE V 
Restoration of EDC Activity to Dialyzed Resin-Treated  Plasma  by  a  Heat-Stable Substange 
Amount 
mr. 
0.03 
Dialyzed plasma 
Reconstituted with 
Dialysate 
Boiled dialysate 
Ashed  " 
Endotoxln 
10 t~g. Serr. 
Induced tumor 
damage* 
1o/lo 
0/t0 
2/10 
0110 
Inactivation 
of endotoxin 
~'one 
Complete 
* No. of mice with damaged tumors/total No. of mice tested. 
in order to ascertain whether the change in endotoxin, as measured by tumor 
damage,  could  also be demonstrated using  other host  reactions as indicator 
systems. 
Skwartzman Reaction.-- 
Serratia marcescens endotoxin was incubated (40 /zg./ml.) for  1 hour at 37°C. with hu- 
man plasma, recalcified  plasma, or with normal saline. Then individual rabbits  (New Zealand 
albinos) were given 0.5 ml. aliquots of each of the three reaction mixtures in the shaved ab- 
dominal skin. The provocative intravenous injection of 20/~g. Salmonella typkosa endotoxin 
was given 18 hours later. The hemorrhagic skin reactions which ensued were read 6 to 8 hours 
thereafter. 
The results of one such test are given in Table VI, and show that the prepar- 
atory activity of 20 t~g. of Serf.  marcescens  endotoxin  (cf.  the  controls)  was 
completely eliminated by 0.5 ml. of human plasma. Following recalcification, 
the plasma no longer affected the preparatory activity of endotoxin. 
1  Footnote added in  tyroof.-Physiologic  levels of phosphate plus bicarbonate have since 
been found to restore EDC activity to the same extent as does the dialysate. ROSEN~ SKARNES~ LANDY~ AND  SHEAR  707 
In another experiment the local Shwartzman reaction was used to measure the potency of 
pooled human plasma in inactivating Serf. mareesc~,ts endotoxin for comparison with the data 
obtained by the tumor-damage assay. For this purpose varying amounts of plasma were in- 
cubated for 1 hour at 37°C. with Serf. marcescens endotoxin so that the aliquots to be injected 
represented amounts of plasma ranging from 0.1  to 0.003  ml., each reacted with 10/xg. of 
TABLE VI 
Elimination of the Shwartzman Preparatory Aaivity of Endotoxin by EDC 
EDC 
Source 
~Iuman ACD 
plasma 
~Iuman reealci- 
fled plasma 
~aline control 
"1 
ml. 
0.5 
Endotoxin 
20 gg. Serf. 
marGe$cen$ 
0 
++++ 
+++ 
Skin preparatory activity in rabbits* 
2 
! 
]  0 
+++ 
++++ 
0 
++ 
++++ 
4  I  s  6 
I 
i 
0  0  0 
I 
+++  +++  +++ 
++++  +++  ++++ 
* Provoked 18 hours later by intravenous injection of 20 ttg. S. typhosa endotoxin. 
TABLE VII 
Titration of EDC in Human Plasma; Inactivation of Shwartzman Preparatory 
Activity of Endotoxin 
Reaction mixture* tested  Skin preparatory activity in rabbits~  for preparatory activity 
Plasma  Endotoxin  A  D 
ml. 
0.1 
0.03 
0.01 
0.005 
0.003 
Saline 
10 gg. Swr. 
marc~c~$ 
0 
0 
Tr 
+++ 
++ 
++ 
B  C 
0  0 
0  0 
0  +++ 
++++  ++++ 
+++  ++++ 
++  ++ 
0 
++++ 
+++ 
* Incubated for 1 hour at 37°C. 
:~ Provoked 18 hours later by intravenous injection of 20 I~g. S. typhosa endotoxin. 
endotoxin. Following incubation all reaction mixtures were brought up to 0.5 ml. with saline 
and injected intradermally in the shaved abdominal skin of each of a number of rabbits;  18 
hours later the animals were given an intravenous provoking dose of 20 #g.  of S. typhosa 
endotoxin and the reactions were read 6 to 8 hours thereafter. 
The results of this experiment, given in Table VII, show that,  as determined 
by Shwartzman preparatory  activity, the EDC  potency of human plasma was 
similar  to  that  determined  by  tumor  damage.  In  both  test  situations  the 708  INACTIVATION OF ENDOTOXIN  BY HUMORAL  COMPONENT.  III 
minimal amounts of plasma which brought about inactivation of the standard 
dose of endotoxin was of the order of 0.01  ml. 
Lethality.--AmOng  the more  common laboratory animals,  rabbits  are  the 
species  most  susceptible  to  the  effects  of  endotoxin.  However,  individual 
animals vary considerably as regards the quantity of a  potent endotoxin re- 
quired to produce death. It was shown by Good and Thomas (3) that rabbits 
pretreated with thorotrast were more susceptible to the lethal effects of endo- 
toxin; i.e.,  a  smaller dose sufficed to kill. 
Consequently, in order to use lethality as still another basis for evaluation of changes in 
endotoxin, New Zealand albino rabbits, weighing 2 to 3 kilograms, were given an intravenous 
TABLE VIII 
Elimination of the Lethal Effect of Typhoid Endotoxin by EDC 
EDC 
Source* 
Human serums 
"  serum,  citrated 
"  plasma,  resin-treated 
....  "  recalcified 
Saline control 
Amount 
ml. 
1 
Endotoxin 
20 ~g. S. typhosa 
LethaH~ for 
~o~tmst 
prepared 
~bbits 
4/4 
0/4 
0/4 
4/4 
4/4 
* These products were all derived from a single specimen of blood. 
0.5 mL of this serum failed to inactivate 10 ~g. of S. marcesvens  endotoxin. 
injection of 3 ml. of thorotrast. Six hours later they received, i.v., 20 #g. of typhoid endotoxin 
which had been incubated in saline, in plasma, or in serum. In the thorotrast-treated animals 
20/~g. of typhoid endotoxin represented a uniformly fatal challenge. 
From the data given in Table VIII it is seen that resin-treated human plasma 
eliminated this lethal effect of endotoxin, whereas after it had been recalcified 
this plasma no longer abolished the lethal property of typhoid endotoxin. On 
the other hand, serum from the same donor (obtained at the same bleeding), 
which failed to inactivate endotoxin as measured by the tumor damage assay, 
likewise failed to prevent death. However, when this same serum was citrated 
and then incubated with typhoid endotoxin the animals showed no ill effects. 
Thus the effects of calcium and of calcium-binding agents on the inactivation of 
endotoxin by EDC are not limited to tumor response but are also evident in 
other host reactions to endotoxins. 
DISCUSSION 
The accompanying  report  described experiments  dealing  with  a  humoral 
component which inactivates endotoxin and whose activity was readily mani- ROSEN, SKARNES, LANDY, AND  SHEAR  709 
fested in citrated plasma whereas little or none was usually apparent in serum. 
It was pointed out that this marked difference was only discernible with an 
appropriate bioassay method and with the use of a suitable anticoagulant. The 
technique used to measure host reactions to endotoxin is of critical importance. 
The assay method employed in that investigation was considered from the stand- 
point of its particular suitability for measurement of alterations in endotoxin 
activity. Only brief mention was made of the crucial role of the anticoagulant 
used in obtaining the plasma. The data reported in this communication require 
that further consideration  be given to this matter. 
It has been shown that EDC activity is inhibited by calcium and certain 
other divalent cations, i.e.,  magnesium, manganese, and barium. Thus the high 
level of activity exhibited  by citrated plasma appears  to have been achieved 
by virtue of the calcium-binding property of the anticoagulant. Similar potency 
was obtained when plasma was derived from blood in which clot formation had 
been  prevented  by  other  calcium-binding  anticoagulants,  such  as  oxalate, 
fluoride, and EDTA, or by the collection of blood through a cation exchange 
resin. On the basis of these findings it was anticipated that the addition of these 
calcium-binding agents to serum would disclose EDC activity where little or 
none was previously evident. This was indeed found to be the case; the addition 
of these agents to serum rendered it as active as citrated plasma. 
While inhibition of EDC activity at first appeared to be a consequence only 
of calcium  concentration, later observations  showed  that  other factors also 
influenced this activity. For one thing, sera from human donors exhibited con- 
siderable differences in EDC potency despite  the constancy of calcium levels. 
Furthermore, in at least one species (rat), serum and citrated plasma were of 
comparable potency. 
Dialysis of plasma against distilled  water removed most of the calcium. 
Contrary to expectation,  the EDC potency of the dialyzed material was found 
to be reduced rather than elevated.  Stepwise restoration of calcium,  by the 
addition of graded increments,  failed to restore  the activity of the dialyzed 
plasma,  excluding the possibility  that low levels of calcium were required  for 
EDC activity. On the other hand, addition of "calcium-binding"  anticoagulants 
fully restored activity to dialyzed plasma. Inasmuch as the latter effect was ob- 
tained with plasma in which the calcium content had been reduced below the 
level of detection, it is clear that neither the inhibition of EDC potency with 
calcium, nor the reversal of this inhibition with calcium-binding anticoagulants 
is explicable  solely on the basis  of calcium ion. Obviously,  some mechanism 
other than the binding of calcium is involved. 
Since such anticoagulants exerted an important effect even in the absence of 
detectable calcium, it was considered desirable to obtain plasma without the use 
of anticoagulant. Accordingly, human blood was passed through a cationic ex- 
change resin to remove most of the calcium; plasma thus obtained proved to be 710  INACTIVATION OF  ENDOTOXIN BY  HUM'ORAI,  COMPONENT.  HI 
as potent as citrated plasma. Dialysis, as in the case of citrated plasma, greatly 
reduced the potency of the resin-collected plasma. However, when this dialysate 
was recombined with the dialyzed plasma, EDC  activity was fully restored. 
Moreover, even after the dialysate was dried and ashed, the aqueous extract of 
the ash restored the potency of the dialyzed plasma to the same extent as did 
the dialysate itself. 
This effect was not attributable to cation for neither divalent (Ca, Mg, Mn, 
Ba, Cu, Co, Fe) or monovalent (Na, K) cations restored activity. Accordingly, 
attention is now being focused on the  anionic content of the dialysate. At 
present this much seems likely: some inorganic anionic component, normally 
present in human plasma, is required for EDC to inactivate endotoxin. 
Much of the published work on the effect of plasma upon endotoxic activity 
was carried out with heparinized plasma. The present study shows that such 
plasma does not differ from serum in EDC activity. It is only when calcium- 
binding anticoagulants are employed that plasmas from mammalian species  are 
capable of inactivating endotoxin; moreover, they then manifest a high activity 
of approximately the same magnitude. This uniformity of effect with plasma 
from various species is not apparent when serum is tested; pronounced vari- 
ability in serum is exhibited not only from one species to another but also among 
individuals within the same species. Appreciation of the critical importance of 
the animal species used as the source of serum, as well as of the methods em- 
ployed in obtaining plasma, may warrant re-evaluation of the conflicting state- 
ments in the literature on the effects of blood upon endotoxin. 
It is still too early a stage in the development of our knowledge of this com- 
ponent to understand its biological implications for the host. It might appear 
that inactivation of endotoxin could not occur in the intact animal in view of the 
inhibition of this reaction in vitro by levels of calcium such as are known to be 
present in dvo. The fact remains, however, that sera from a number of species 
exhibit EDC activity despite normal calcium levels. From the limited informa- 
tion now available, it appears that calcium does not directly inhibit the inacti- 
vation of endotoxin but rather that it may exert its influence indirectly; i.e., 
through its effect on some anion which is required for EDC activity. 
At present it is not known how the host detoxifies endotoxin. It is now ac- 
cepted that the cells  of the RES take up endotoxin and remove it from the 
circulation (4).  This clearing of endotoxin from the blood does not, however, 
explain how the toxicity of phagocytized endotoxin is ultimately terminated. 
The possibility should be  considered that EDC  contributes to  the ultimate 
detoxification of endotoxin in the circulating blood or within cells. 
i  S~YM~RY 
The uniformly high potency of citrated plasma as compared with the limited 
capacity of serum to inactivate endotoxin in dlro was found to be a  conse- 
quence of the anticoagulant employed in  collecting the plasma. ROSEN, SKARNES, LANDY~ AND SHEAR  711 
Addition of calcium to plasma suppressed the activity of its endotoxin de- 
toxifying component (EDC)  whereas the addition of calcium-binding antico- 
agulants  rendered  serum  comparable  to  plasma. 
Dialysis of plasma resulted in a marked reduction of its EDC activity despite 
the concomitant elimination of calcium. EDC activity could then be fully re- 
stored upon the addition of calcium-binding anticoagulants. 
Resin-treated plasma, without added anticoagulant, had EDC activity equal 
to plasma obtained with calcium-binding anticoagulants. Following dialysis, 
resin-treated plasma also sustained a marked reduction in EDC activity which 
could be fully restored by calcium-binding anticoagulants. Restoration was also 
obtained with the dialysate even after ashing. 
These findings indicated that the suppression of EDC activity by calcium is 
not direct but is mediated through its effects on an anionic component of plasma 
which is required for inactivation of endotoxin by EDC. 
BIBLIOGRAPHY 
1.  Landy, M., Skames, R. C., Rosen, F. S., Trapani, R-J., and  Shear,  M.  J.,  In- 
activation of biologically active ("endotoxic") polysaccharides by fresh  hutnan 
serum, Proc. Soc. Exp. Biol. and Med., 1957, 96, 744. 
2.  Skarnes, R. C., Rosen, F. S., Shear, M. J., and Landy, M., Inactivation of endo- 
toxin by a humoral component.  II. Interaction of endotoxin with serum  and 
plasma, Y. Exp. Med., 1958, 108, 685. 
3.  Good, R. A., and Thomas, L., Studies on the generalized Shwartzman reaction. 
II. The production of bilateral  cortical necrosis of the kidneys by a single in- 
jection of bacterial toxin in rabbits previously treated with Thorotrast or trypan 
blue, J. Exp. Med., 1952, 96, 625. 
4.  Thomas, L., The role of the reticulo-endothelial system in the reaction  to endo- 
toxins, in Physio-pathology of the Reticulo-Endothelial  System, (Edited under 
the  direction  of B. N. Halpern, B. Benacerraf,  J.  L. Delafresnaye),  Oxford, 
England, Blackwell Scientific Publications,  1957. 